Rare diseases
Investigational molecules
Locations
16 Rue Montrosier, 92200 Neuilly-Sur-Seine, France
Theravia’s clinical research is centered on sickle cell disease, with attention to treatment needs in paediatric patients and the management of chronic haematological symptoms. The funded study focuses on children aged 9 months to 11 years, reflecting interest in early-life disease care and age-appropriate therapy.
The sponsor’s research activity includes clinical evaluation of oral dispersible formulations used in children with sickle cell disease, supporting therapeutic development in paediatric haematology.
Theravia runs clinical trials in conditions such as Sickle cell disease, among others.
Clinical trials run by this sponsor – those enrolling participants first.
FranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
